Aim To assess triglyceride-to high-density lipoprotein cholesterol (TG/HDL)-C ratio in patients with acute coronary syndrome (ACS) and to verify its association with renal dysfunction. Methods A cross sectional study included 85 ACS patients divided in two groups with (ACS-RD) and without (ACS-nRD) presence of renal dysfunction, and 35 healthy subjects. Blood pressure, blood glucose, C-reactive protein, urea, creatinine, eGFR and serum lipids levels (total cholesterol, triglycerides, LDL-C, HDL-C) was measured in all participants. Based on the values of the measured lipid fractions TG/HDLc ratio was calculated. Results Patients in ACS group had significantly lower HDL-C level (p<0.0005) but significantly higher TG level (p=0.046) and TG/HDL-C ratio (p<0.0005) than controls. There was a significant increase (p<0.0005) in TG/HDL-C ratio in ACS-RD group compared to ACS-nRD group. The ACS-RD group had significantly higher level of TG (p=0.001), serum urea (p=0.02) and creatinine (p<0.0005) compared to the ACS-nRD group. With a cutoff level of 1.135 TG/HDL-C ratio had a sensitivity of 77.6% and a specificity of 62.9% in distinguishing between ACS patients and healthy subjects. With cutoff value of 1.905 TG/HDL-C ratio had a sensitivity of 75.9% and a specificity of 78.6% in distinguishing between ACS patients with and without renal dysfunction. Conclusion This study confirms the reliability of the TG/HDL-C ratio as a simple, low cost and useful marker in distinguishing between patients with ACS and healthy subjects and ACS patients with and without renal dysfunction.
Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin Biochem 2001:583–8.
2
Kim J, Kim W, Woo J, Lee T, Ihm C, Kim Y, et al. Korea Acute Myocardial Infarction Registry Investigators. The predictive role ofsSerum triglyceride to high-density lipoprotein cholesterol ratio according to renal function in patients with acute myocardial infarction. PLoS ONE 2016:165484.
3
Chen H, Tsai W, Chiu Y, Hsu S, Pai M, Ng Y, et al. Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients. Medicine (Baltimore) 2015:619.
4
Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol 2013:1605–12.
5
Sieber J, Jehle A. Free fatty acids and their metabolism affect function and survival of podocytes. Front Endocrinol 2014:186.
6
Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, et al. Clinical usefulness of urinary liver fatty acid-binding protein excretion for predicting acute kidney injury during the first 7 days and the short-term prognosis in acute heart failure patients with non-chronic kidney disease. Cardiorenal Med 2017:301–15.
7
Sonmez A, Yilmaz M, Saglam M, Unal H, Gok M, Cetinkaya H, et al. The role of plasma triglyceride/high density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease. Lipids Health Dis 2015:29.
8
Sengsuk J, Tangvarasittichai O, Tangvarasittichai S. Increased triglycerides and high density lipoprotein ratio associated with progression of chronic kidney disease in patients with type 2 diabetes mellitus. Diabetes Obes Int J 2017:166.
9
Da Luz P, Favarato D, Junior J-N, Lemos P, Chagas A. High ratio of triglycerides to HDLcholesterol predicts extensive coronary disease 2008:427–32.
10
Maki K, Davidson M, Dicklin M, Bell M, Witchger M, Feinstein S. Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease. J Clin Lipidol 2011:141–51.
11
Bittner V, Johnson B, Zineh I, Rogers W, Vido D, Marroquin O, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia. Am Heart J 2009:548–55.
12
Shishehbor M, Hoogwerf B, Lauer M. Association of triglyceride to-HDL cholesterol ratio with heart rate recovery. Diabetes Care 2004:936–41.
13
Drexel H, Aczel S, Marte T, Benzer W, Langer P, Moll W, et al. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 2005:101–7.
14
Zhang W, Yu J, Wang X, X. Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention. Medicine 2017:5469.
15
Marenzi G, Cosentino N, Bartorelli A. Acute kidney injury in patients with acute coronary syndromes. Heart 2015:1–8.
16
Fox C, Muntner P, Chen A, Alexander, Roe M, Cannon C, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease. Circulation 2010:357–65.
17
Gupta T, Harikrishnan P, Kolte D, Khera S, Subramanian K, Mujib M, et al. Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. Am J Cardiol 2015:1033–41.
18
Amin A, Salisbury A, Mccullough P, Gosch K, Spertus J, Venkitachalam L, et al. Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med 2012:246–53.
19
Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D. A More Accurate Method to Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Annals of Internal Medicine 1999:461–70.
20
Amsterdam E, Wenger N. American College of Cardiology ACC/American Heart Association Guideline for the management of patients with non-ST-elevation acute coronary syndromes: ten contemporary recommendations to aid clinicians in optimizing patient outcomes. Clin Cardiol 2014:121–3.
21
Claudio R, Mikko H. House Andrew A. Cardiorenal syndrome. J Am Coll Cardiol 2008:1527–39.
22
Salazar M, Carbajal H, Espeche W, Sisnieguez L, Balbín C, Dulbecco E, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardio 2012:1749–53.
23
Chang T, Streja E, Soohoo M, Kim T, Rhee C, Kovesdy C, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol 2017:591–602.
24
Da Luz P, Cesena F, Favarato D, Cerqueira E. Comparison of serum lipid values in patients with coronary artery disease at <50, 50 to 59, 60 to 69, and >70 years of age. Am J Cardiol 2005:1640–3.
25
Wen J, Zhong Y, Wen Z, Kuang C, Liao J, Chen L, et al. Triglyceride to HDL-C ratio and increased arterial stiffness in apparently healthy individuals. Int J Clin Exp Med 2015:4342–8.
26
Penalva R, Huoya M, Correia L, Feitosa G, Ladeia A. Lipid profile and intensity of atherosclerosis disease in acute coronary syndrome. Arq Bras Cardiol 2008:24–30.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
